Alexion Pharmaceuticals
Headquartered in Cheshire, Connecticut (USA), Alexion is global biopharmaceutical company focused on the development and delivery of life-transforming therapies for patients with severe and life-threatening rare disorders.
Financial Data
-
31st Dec 20 Source: CRO
- €2.3 billion turnover
-
€1.3 billion
profit - 400 employees
-
31st Dec 19 Source: CRO
- €2.5 billion turnover
-
€1.5 billion
profit - 400 employees
- 6 more years available »
Ranking
By Turnover
(€2.3 billion)- 53rd in Top Companies
- 10th in Health
- 9th in Pharma
By Employees
(400)- 421st in Top Companies
- 62nd in Health
- 35th in Pharma
- 400
- €2.3 billion
Employees
- Shane Doyle Senior vice president
Latest News
- May 24 Harsh winter may compel Europe to ration gas, warns International Energy Agency
- May 24 Hungary and Poland hold up EU decisions on oil and corporate tax
- May 24 Over 700 objections lodged against €466m Dundrum apartment ‘concrete jungle’
- May 24 Stripe unveils new third party app marketplace
- May 24 Shares in UK energy companies slide over windfall tax fears